US Patent Issued to GeoVax on March 17 for "Vaccines and uses thereof to induce an immune response to SARS-CoV2" (Georgia Inventors)

ALEXANDRIA, Va., March 17 -- United States Patent no. 12,577,589, issued on March 17, was assigned to GeoVax Inc. (Smyrna, Ga.).

"Vaccines and uses thereof to induce an immune response to SARS-CoV2" was invented by Mary Jo Hauser (Marietta, Ga.), Arban Domi (Atlanta) and Farshad Guirakhoo (Atlanta).

According to the abstract* released by the U.S. Patent & Trademark Office: "Provided herein are recombinant modified vaccinia Ankara (rMVA) viral vectors comprising heterologous nucleic acid inserts encoding one or more SARS-CoV2 proteins, peptides, or fragments thereof, operably linked to a promoter compatible with poxvirus expression systems that, upon expression, are capable of inducing protective immunity. The compositions can be used in a...